Maaike Pelsma

Maaike Pelsma

Auto-generated profile, based on publicly available information

Maaike Pelsma

Department of Rehabilitation, Amalia Children's Hospital Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center Nijmegen the Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2021 in Neurology
Verified
Journal Article
Open access
PDF file
JDJildou N. Dijkstra
Jildou N. Dijkstra
RGRianne J.M. Goselink
Rianne J.M. Goselink
NANens van Alfen
Nens van Alfen
IGImelda J.M. de Groot
Imelda J.M. de Groot
MPMaaike Pelsma
Maaike Pelsma
CECorrie E. Erasmus
Corrie E. Erasmus
Background and Objectives Data on the natural history of facioscapulohumeral dystrophy (FSHD) in childhood are limited and critical for improved patient care and clinical trial readiness. Our objective was to describe the disease course of FSHD in children. Methods We performed a nationwide, single-center, prospective cohort study of FSHD in childhood assessing muscle functioning, imaging, and quality of life over 2 years of follow-up. Results We included 20 children with genetically confirmed FSHD who were 2 to 17 years of age. Overall, symptoms were slowly progressive, and the mean FSHD clinical score increased from 2.1 to 2.8 (p = 0.003). The rate of progression was highly variable. At baseline, 16 of 20 symptomatic children had facial weakness; after 2 years, facial weakness was observed in 19 of 20 children. Muscle strength did not change between baseline and follow-up. The most frequently and most severely affected muscles were the trapezius and deltoid. The functional exercise capacity, measured with the 6-minute walk test, improved. Systemic features were infrequent and nonprogressive. Weakness-associated complications such as lumbar hyperlordosis and dysarthria were common, and their prevalence increased during follow-up. Pain and fatigue were frequent complaints in children, and their prevalence also increased during follow-up. Muscle ultrasonography revealed a progressive increase in echogenicity. Discussion FSHD in childhood has a slowly progressive but variable course over 2 years of follow-up. The most promising outcome measures to detect progression were the FSHD clinical score and muscle ultrasonography. Despite this disease progression, an improvement on functional capacity may still occur as the child grows up. Pain, fatigue, and a decreased quality of life were common symptoms and need to be addressed in the management of childhood FSHD. Our data can be used to counsel patients and as baseline measures for treatment trials in childhood FSHD.

23 December 2022 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
SOSaskia L. S. Houwen‐Van Opstal
Saskia L. S. Houwen‐Van Opstal
RTRamon O. Tak
Ramon O. Tak
MPMaaike Pelsma
Maaike Pelsma
FHFrederik van den Heuvel
Frederik van den Heuvel
HDHermine A. van Duyvenvoorde
Hermine A. van Duyvenvoorde
MWMichèl Willemsen
Michèl Willemsen
Aim: To study long‐term disease course for females with early‐onset dystrophinopathy, including common (female) symptoms, challenges in social participation, the need for care, and current healthcare management to support guideline development.Method: Twelve females with early‐onset dystrophinopathy were followed for a median period of more than 17 years (range 1–36).Results: One patient died owing to end‐stage cardiac failure. Cardiac abnormalities were observed in three of the remaining 11 participants. Respiratory function was reduced in seven of 10 participants. Fatigue, myalgia, lower back pain, and arthralgia were reported in more than six of the participants. Functional status varied from exercise intolerance to wheelchair dependency. Most or all of the 10 participants reported restrictions in participation in work (n = 10), household duties (n = 10), sports (n = 9), and education (n = 8). Only a few participants received followed‐up pulmonary (n = 2) or rehabilitation (n = 3) care.Interpretation: Females with early‐onset dystrophinopathy experience a wide range of impairments, comorbidities, limitations in activities, and restrictions in social participation. The whole spectrum should be acknowledged in the healthcare setting. Neuromuscular and cardiac follow‐up are indispensable. Additional respiratory assessment and rehabilitation care are expected to improve health status and support daily activities and participation.What this paper adds: No standard diagnostic procedures seem to exist for female patients suspected for dystrophinopathy. Female participants with early‐onset dystrophinopathy experienced a broad scope of burdening symptoms, such as fatigue, myalgia, lower back pain, and arthralgia. None of participants worked full time, all felt restricted in paid work, and most felt restricted in education. Most participants showed decreased lung function, while only one was symptomatic. Availability of rehabilitation care may improve support for daily activities and participation for females with early‐onset dystrophinopathy.